Recursion Pharmaceuticals Inc. (RXRX) Revenue Analysis | Historical Sales Growth & Trends - Stocknear

Recursion Pharmaceuticals...

NASDAQ: RXRX · Real-Time Price · USD
4.61
0.09 (1.99%)
At close: Sep 05, 2025, 3:59 PM
4.62
0.22%
After-hours: Sep 05, 2025, 07:56 PM EDT

Recursion Pharmaceuticals Revenue

Recursion Pharmaceuticals reported an annual revenue of $58.84M, reflecting a 32% growth. For the quarter ending June 30, 2025, Recursion Pharmaceuticals generated $19.1M in revenue.
Revenue (ttm)
58.84M
Revenue Growth
32%
Price / Sales Ratio
31.5
Revenue / Employee
73.55K
Employees
800
Market Cap
1.97B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 58.84M +32.00%
Dec 31, 2023 44.58M +12.33%
Dec 31, 2022 39.68M +296.81%
Dec 31, 2021 10M +193.00%
Dec 31, 2020 3.41M +99.47%
Dec 31, 2019 1.71M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.